Username


Password

Preview

Marie-Paule Merville

Publications

  • TOP 3
  • Dominique de Seny; Mohammed Sharif; Marianne Fillet; Gaël Cobraiville; Marie-Alice Meuwis; Raphaël Marée; Jean-Philippe Hauzeur; Louis Wehenkel; Edouard Louis; Marie-Paule Merville; et al.
    Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis.
  • Aurore Keutgens; Xin Zhang; Kateryna Shostak; Isabelle Robert; Sabine Olivier; Alain Vanderplasschen; Jean-Paul Chapelle; Patrick Viatour; Marie-Paule Merville; Françoise Bex; et al.
    BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
  • Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Anne-Catherine Servais; Tran Quang Minh; Jean Closset; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; et al.
    Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis.
Register to see all publications

Register for free to view:

Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the research activity
of experts around the globe
Register to see more

Geonetwork of Marie-Paule Merville (preview)

  • Cities where this author has publications
  • Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

  • 2011: Dominique de Seny; Mohammed Sharif; Marianne Fillet; Gaël Cobraiville; Marie-Alice Meuwis; Raphaël Marée; Jean-Philippe Hauzeur; Louis Wehenkel; Edouard Louis; Marie-Paule Merville; et al.
    Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis.
    Annals of the rheumatic diseases 2011;70(6):1144-52.
  • 2010: Aurore Keutgens; Xin Zhang; Kateryna Shostak; Isabelle Robert; Sabine Olivier; Alain Vanderplasschen; Jean-Paul Chapelle; Patrick Viatour; Marie-Paule Merville; Françoise Bex; et al.
    BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
    The Journal of biological chemistry 2010;285(33):25831-40.
  • 2010: Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Anne-Catherine Servais; Tran Quang Minh; Jean Closset; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; et al.
    Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis.
    Talanta 2010;82(1):245-54.
  • 2010: Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
    Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.
    Journal of biomedicine & biotechnology 2010;2010():906082.
  • 2009: I Robert; M Aussems; A Keutgens; X Zhang; B Hennuy; P Viatour; G Vanstraelen; M-P Merville; J-P Chapelle; L de Leval; et al.
    Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.
    Oncogene 2009;28(13):1626-38.
  • 2009: Florence Quesada Calvo; Marianne Fillet; Dominique de Seny; Marie-Alice Meuwis; Raphael Maree; Céline Crahay; Geneviève Paulissen; Natacha Rocks; Maud Gueders; Louis Wehenkel; et al.
    Biomarker discovery in asthma-related inflammation and remodeling.
    Proteomics 2009;9(8):2163-70.
  • 2009: D De Seny; C Ribbens; G Cobraiville; M A Meuwis; R Marée; P Geurts; L Wehenkel; E Louis; M P Merville; M Fillet; et al.
    [Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest].
    Revue médicale de Liège 2009;64 Spec No():29-35.
  • 2008: Marie-Alice Meuwis; Marianne Fillet; Laurence Lutteri; Raphaël Marée; Pierre Geurts; Dominique de Seny; Michel Malaise; Jean-Paul Chapelle; Louis Wehenkel; Jacques Belaiche; et al.
    Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study.
    Clinical biochemistry 2008;41(12):960-7.
  • 2008: Julie Crèvecoeur; Marie-Paule Merville; Jacques Piette; Geoffrey Gloire
    Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
    Biochemical pharmacology 2008;75(11):2183-91.
  • 2008: Dominique de Seny; Marianne Fillet; Clio Ribbens; Raphaël Marée; Marie-Alice Meuwis; Laurence Lutteri; Jean-Paul Chapelle; Louis Wehenkel; Edouard Louis; Marie-Paule Merville; et al.
    Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis.
    Clinical chemistry 2008;54(6):1066-75.
  • 2008: Isabelle Cornez; Catherine Creppe; Magali Gillard; Benoît Hennuy; Jean-Paul Chapelle; Emmanuel Dejardin; Marie-Paule Merville; Pierre Close; Alain Chariot
    Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells.
    Biochemical pharmacology 2008;75(11):2122-34.
  • 2008: Marie-Alice Meuwis; Marianne Fillet; Jean-Paul Chapelle; Michel Malaise; Edouard Louis; Marie-Paule Merville
    New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.
    Expert review of molecular diagnostics 2008;8(3):327-37.
  • 2007: Cécile Lambert; Cécile Oury; Emmanuel Dejardin; Alain Chariot; Jacques Piette; Michel Malaise; Marie-Paule Merville; Nathalie Franchimont
    Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(9):1350-61.
  • 2007: Marie-Alice Meuwis; Marianne Fillet; Pierre Geurts; Dominique de Seny; Laurence Lutteri; Jean-Paul Chapelle; Vincent Bours; Louis Wehenkel; Jacques Belaiche; Michel Malaise; et al.
    Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling.
    Biochemical pharmacology 2007;73(9):1422-33.
  • 2006: V Benoit; E de Moraes; N A Dar; E Taranchon; V Bours; A Hautefeuille; P Tanière; A Chariot; J-Y Scoazec; C V de Moura Gallo; et al.
    Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB.
    Oncogene 2006;25(42):5708-18.
  • 2006: Biserka Relic; Valérie Benoit; Nathalie Franchimont; Marie-Joelle Kaiser; Jean-Philippe Hauzeur; Philippe Gillet; Marie-Paule Merville; Vincent Bours; Michel G Malaise
    Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis.
    The Journal of biological chemistry 2006;281(32):22597-604.
  • 2006: Pierre Close; Nicola Hawkes; Isabelle Cornez; Catherine Creppe; Charles A Lambert; Bernard Rogister; Ulrich Siebenlist; Marie-Paule Merville; Susan A Slaugenhaupt; Vincent Bours; et al.
    Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia.
    Molecular cell 2006;22(4):521-31.
  • 2006: Sabine Olivier; Pierre Close; Emilie Castermans; Laurence de Leval; Sebastien Tabruyn; Alain Chariot; Michel Malaise; Marie-Paule Merville; Vincent Bours; Nathalie Franchimont
    Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
    Molecular pharmacology 2006;69(5):1615-23.
  • 2006: Marianne Bonif; Marie-Alice Meuwis; Pierre Close; Valérie Benoit; Karen Heyninck; Jean-Paul Chapelle; Vincent Bours; Marie-Paule Merville; Jacques Piette; Rudi Beyaert; et al.
    TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
    The Biochemical journal 2006;394(Pt 3):593-603.
  • 2005: Dominique de Seny; Marianne Fillet; Marie-Alice Meuwis; Pierre Geurts; Laurence Lutteri; Clio Ribbens; Vincent Bours; Louis Wehenkel; Jacques Piette; Michel Malaise; et al.
    Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    Arthritis and rheumatism 2005;52(12):3801-12.
  • 2005: Pierre Geurts; Marianne Fillet; Dominique de Seny; Marie-Alice Meuwis; Michel Malaise; Marie-Paule Merville; Louis Wehenkel
    Proteomic mass spectra classification using decision tree based ensemble methods.
    Bioinformatics (Oxford, England) 2005;21(14):3138-45.
  • 2005: M Fillet; C Cren-Olivé; A-F Renert; J Piette; F Vandermoere; Ch Rolando; M-P Merville
    Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS.
    Journal of proteome research 2005;4(3):870-80.
  • 2005: Sabine Olivier; Marianne Fillet; Michel Malaise; Jacques Piette; Vincent Bours; Marie-Paule Merville; Nathalie Franchimont
    Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene.
    Biochemical pharmacology 2005;69(6):891-901.
  • 2005: Chantal Lechanteur; Nathalie Jacobs; Roland Greimers; Valérie Benoît; Valérie Deregowski; Alain Chariot; Marie-Paule Merville; Vincent Bours
    Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis.
    Oncogene 2005;24(10):1788-93.
  • 2005: Pierre A Robe; Minh Nguyen-Khac; Olivier Jolois; Bernard Rogister; Marie-Paule Merville; Vincent Bours
    Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.
    BMC cancer 2005;5():32.
  • 2005: Patrick Viatour; Marie-Paule Merville; Vincent Bours; Alain Chariot
    Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
    Trends in biochemical sciences 2005;30(1):43-52.
  • 2005: Nathalie Franchimont; Cécile Lambert; Pascale Huynen; Clio Ribbens; Biserka Relic; Alain Chariot; Vincent Bours; Jacques Piette; Marie-Paule Merville; Michel Malaise
    Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
    Arthritis and rheumatism 2005;52(1):84-93.
  • 2004: Patrick Viatour; Marie-Paule Merville; Vincent Bours; Alain Chariot
    Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity.
    Cell cycle (Georgetown, Tex.) 2004;3(12):1498-501.
  • 2004: Patrick Viatour; Emmanuel Dejardin; Michael Warnier; Florence Lair; Estefania Claudio; Fabrice Bureau; Jean-Christophe Marine; Marie-Paule Merville; Ulrich Maurer; Douglas Green; et al.
    GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.
    Molecular cell 2004;16(1):35-45.
  • 2004: Pierre A Robe; Mohamed Bentires-Alj; Marianne Bonif; Bernard Rogister; Manuel Deprez; Heddi Haddada; Minh-Tuan Nguyen Khac; Olivier Jolois; Kadir Erkmen; Marie-Paule Merville; et al.
    In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5595-603.
  • 2004: Pierre A Robe; Olivier Jolois; Minh N'Guyen; Frederic Princen; Brigitte Malgrange; Marie-Paule Merville; Vincent Bours
    Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication.
    International journal of oncology 2004;25(1):187-92.
  • 2004: Biserka Relic; Valérie Benoit; Nathalie Franchimont; Clio Ribbens; Marie-Joelle Kaiser; Philippe Gillet; Marie-Paule Merville; Vincent Bours; Michel G Malaise
    15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts.
    The Journal of biological chemistry 2004;279(21):22399-403.
  • 2004: Valérie Benoit; Alain Chariot; Laurence Delacroix; Valérie Deregowski; Nathalie Jacobs; Marie-Paule Merville; Vincent Bours
    Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression.
    Cancer research 2004;64(8):2684-91.
  • 2004: Dominique M Jans; Wim Martinet; Marianne Fillet; Mark M Kockx; Marie-Paule Merville; Hidde Bult; Arnold G Herman; Guido R Y De Meyer
    Effect of non-steroidal anti-inflammatory drugs on amyloid-beta formation and macrophage activation after platelet phagocytosis.
    Journal of cardiovascular pharmacology 2004;43(3):462-70.
  • 2004: Valérie Benoit; Biserka Relic; Xavier de Leval Xd; Alain Chariot; Marie-Paule Merville; Vincent Bours
    Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2.
    Oncogene 2004;23(8):1631-5.
  • 2003: Patrick Viatour; Sylvie Legrand-Poels; Carine van Lint; Michael Warnier; Marie-Paule Merville; Jacques Gielen; Jacques Piette; Vincent Bours; Alain Chariot
    Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.
    The Journal of biological chemistry 2003;278(47):46541-8.
  • 2003: P Viatour; M Bentires-Alj; A Chariot; V Deregowski; L de Leval; M-P Merville; V Bours
    NF- kappa B2/p100 induces Bcl-2 expression.
    Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(7):1349-56.
  • 2003: Marianne Fillet; Mohamed Bentires-Alj; Valerie Deregowski; Roland Greimers; Jacques Gielen; Jacques Piette; Vincent Bours; Marie-Paule Merville
    Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity.
    Biochemical pharmacology 2003;65(10):1633-42.
  • 2003: Alain Chariot; Marie-Alice Meuwis; Marianne Bonif; Antonio Leonardi; Marie-Paule Merville; Jacques Gielen; Jacques Piette; Ulrich Siebenlist; Vincent Bours
    NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets.
    Current medicinal chemistry 2003;10(7):593-602.
  • 2003: Michel Frédérich; Mohamed Bentires-Alj; Monique Tits; Luc Angenot; Roland Greimers; Jacques Gielen; Vincent Bours; Marie-Paule Merville
    Isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis, induces cell cycle arrest and apoptosis in human colon cancer cells.
    The Journal of pharmacology and experimental therapeutics 2003;304(3):1103-10.
  • 2003: Mohamed Bentires-Alj; Veronique Barbu; Marianne Fillet; Alain Chariot; Biserka Relic; Nathalie Jacobs; Jacques Gielen; Marie-Paule Merville; Vincent Bours
    NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells.
    Oncogene 2003;22(1):90-7.
  • 2003: X de Leval; V Benoit; J Delarge; F Julémont; B Masereel; B Pirotte; M P Merville; J L David; J M Dogné
    Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation.
    Prostaglandins, leukotrienes, and essential fatty acids 2003;68(1):55-9.
  • 2002: Biserka Relić; Mohamed Bentires-Alj; Clio Ribbens; Nathalie Franchimont; Pierre-André Guerne; Valerie Benoît; Marie-Paule Merville; Vincent Bours; Michel G Malaise
    TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB.
    Laboratory investigation; a journal of technical methods and pathology 2002;82(12):1661-72.
  • 2002: Valérie Deregowski; Sylvie Delhalle; Valérie Benoit; Vincent Bours; Marie-Paule Merville
    Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells.
    Biochemical pharmacology 2002;64(5-6):873-81.
  • 2002: Sylvie Delhalle; Valérie Deregowski; Valérie Benoit; Marie-Paule Merville; Vincent Bours
    NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis.
    Oncogene 2002;21(24):3917-24.
  • 2002: Fabrice Bureau; Alain Vanderplasschen; Fabrice Jaspar; Frédéric Minner; Paul-Pierre Pastoret; Marie-Paule Merville; Vincent Bours; Pierre Lekeux
    Constitutive nuclear factor-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins.
    Blood 2002;99(10):3683-91.
  • 2001: L Fiévez; N Kirschvink; S Dogné; F Jaspar; M P Merville; V Bours; P Lekeux; F Bureau
    Impaired accumulation of granulocytes in the lung during ozone adaptation.
    Free radical biology & medicine 2001;31(5):633-41.
  • 2001: M Bentires-Alj; E Dejardin; P Viatour; C Van Lint; B Froesch; J C Reed; M P Merville; V Bours
    Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.
    Oncogene 2001;20(22):2805-13.
  • 2001: F Princen; P Robe; D Gros; T Jarry-Guichard; J Gielen; M P Merville; V Bours
    Rat gap junction connexin-30 inhibits proliferation of glioma cell lines.
    Carcinogenesis 2001;22(3):507-13.
  • 2000: A C Hellin; M Bentires-Alj; M Verlaet; V Benoit; J Gielen; V Bours; M P Merville
    Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis.
    The Journal of pharmacology and experimental therapeutics 2000;295(3):870-8.
  • 2000: V Bours; G Bonizzi; M Bentires-Alj; F Bureau; J Piette; P Lekeux; M Merville
    NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment.
    Toxicology 2000;153(1-3):27-38.
  • 2000: F Bureau; S Delhalle; G Bonizzi; L Fiévez; S Dogné; N Kirschvink; A Vanderplasschen; M P Merville; V Bours; P Lekeux
    Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma.
    Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5822-30.
  • 2000: V Bours; M Bentires-Alj; A C Hellin; P Viatour; P Robe; S Delhalle; V Benoit; M P Merville
    Nuclear factor-kappa B, cancer, and apoptosis.
    Biochemical pharmacology 2000;60(8):1085-9.
  • 2000: V Benoit; A C Hellin; S Huygen; J Gielen; V Bours; M P Merville
    Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
    Oncogene 2000;19(41):4787-94.
  • 2000: P A Robe; B Rogister; M P Merville; V Bours
    Growth regulation of astrocytes and C6 cells by TGFbeta1: correlation with gap junctions.
    Neuroreport 2000;11(13):2837-41.
  • 2000: C Lechanteur; P Delvenne; F Princen; M Lopez; G Fillet; J Gielen; M P Merville; V Bours
    Combined suicide and cytokine gene therapy for peritoneal carcinomatosis.
    Gut 2000;47(3):343-8.
  • 2000: P A Robe; F Princen; D Martin; B Malgrange; A Stevenaert; G Moonen; J Gielen; M Merville; V Bours
    Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.
    Biochemical pharmacology 2000;60(2):241-9.
  • 2000: C Lechanteur; M Moutschen; F Princen; M Lopez; E Franzen; J Gielen; V Bours; M P Merville
    Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells.
    Cancer gene therapy 2000;7(5):676-82.
  • 2000: F Bureau; G Bonizzi; N Kirschvink; S Delhalle; D Desmecht; M P Merville; V Bours; P Lekeux
    Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma.
    American journal of respiratory and critical care medicine 2000;161(4 Pt 1):1314-21.
  • 2000: F Princen; C Lechanteur; M Lopez; J Gielen; V Bours; M P Merville
    Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosis.
    Journal of drug targeting 2000;8(2):79-89.
  • 2000: M Bentires-Alj; A C Hellin; C Lechanteur; F Princen; M Lopez; G Fillet; J Gielen; M P Merville; V Bours
    Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.
    Cancer gene therapy 2000;7(1):20-6.
  • 2000: G Bonizzi; J Piette; M P Merville; V Bours
    Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.
    Biochemical pharmacology 2000;59(1):7-11.
  • 1999: A Chariot; J Gielen; M P Merville; V Bours
    The homeodomain-containing proteins: an update on their interacting partners.
    Biochemical pharmacology 1999;58(12):1851-7.
  • 1999: F Princen; P Robe; C Lechanteur; M Mesnil; J M Rigo; J Gielen; M P Merville; V Bours
    A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
    Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3639-44.
  • 1999: J Y Matroule; A C Hellin; P Morlière; A S Fabiano; R Santus; M P Merville; J Piette
    Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization.
    Photochemistry and photobiology 1999;70(4):540-8.
  • 1999: A Chariot; C van Lint; M Chapelier; J Gielen; M P Merville; V Bours
    CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein.
    Oncogene 1999;18(27):4007-14.
  • 1999: E Dejardin; V Deregowski; M Chapelier; N Jacobs; J Gielen; M P Merville; V Bours
    Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells.
    Oncogene 1999;18(16):2567-77.
  • 1999: G Bonizzi; J Piette; S Schoonbroodt; M P Merville; V Bours
    Role of the protein kinase C lambda/iota isoform in nuclear factor-kappaB activation by interleukin-1beta or tumor necrosis factor-alpha: cell type specificities.
    Biochemical pharmacology 1999;57(6):713-20.
  • 1999: G Bonizzi; J Piette; S Schoonbroodt; R Greimers; L Havard; M P Merville; V Bours
    Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.
    Molecular and cellular biology 1999;19(3):1950-60.
  • 1999: A Chariot; F Princen; J Gielen; M P Merville; G Franzoso; K Brown; U Siebenlist; V Bours
    IkappaB-alpha enhances transactivation by the HOXB7 homeodomain-containing protein.
    The Journal of biological chemistry 1999;274(9):5318-25.
  • 1999: M Bentires-Alj; A C Hellin; M Ameyar; S Chouaib; M P Merville; V Bours
    Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs.
    Cancer research 1999;59(4):811-5.
  • 1998: F Princen; C Lechanteur; M Lopez; G Rocoux; B Detroz; J Gielen; G Fillet; M P Merville; V Bours
    Repeated cycles of retrovirus-mediated HSVtk gene transfer plus ganciclovir increase survival of rats with peritoneal carcinomatosis.
    Gene therapy 1998;5(8):1054-60.
  • 1998: E Dejardin; V Deregowski; R Greimers; Z Cai; S Chouaib; M P Merville; V Bours
    Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells.
    Oncogene 1998;16(25):3299-307.
  • 1998: P D de Maisieres; L Baudoux-Tebache; M P Merville; B Rentier; V Bours; J Piette
    Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kappaB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region.
    The Journal of biological chemistry 1998;273(22):13636-44.
  • 1998: A C Hellin; P Calmant; J Gielen; V Bours; M P Merville
    Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug.
    Oncogene 1998;16(9):1187-95.
  • 1998: C Lechanteur; F Princen; S Lo Bue; B Detroz; G Fillet; J Gielen; V Bours; M P Merville
    HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis.
    Advances in experimental medicine and biology 1998;451():115-9.
  • 1997: G Bonizzi; J Piette; M P Merville; V Bours
    Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells.
    Journal of immunology (Baltimore, Md. : 1950) 1997;159(11):5264-72.
  • 1997: J Piette; B Piret; G Bonizzi; S Schoonbroodt; M P Merville; S Legrand-Poels; V Bours
    Multiple redox regulation in NF-kappaB transcription factor activation.
    Biological chemistry 1997;378(11):1237-45.
  • 1997: C Lechanteur; F Princen; S Lo Bue; B Detroz; G Fillet; J Gielen; V Bours; M P Merville
    HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosis.
    Gene therapy 1997;4(11):1189-94.
  • 1996: G Bonizzi; E Dejardin; B Piret; J Piette; M P Merville; V Bours
    Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates.
    European journal of biochemistry / FEBS 1996;242(3):544-9.
  • 1996: B Rentier; J Piette; L Baudoux; S Debrus; P Defechereux; M P Merville; C Sadzot-Delvaux; S Schoonbroodt
    Lessons to be learned from varicella-zoster virus.
    Veterinary microbiology 1996;53(1-2):55-66.
  • 1996: S Schoonbroodt; J Piette; L Baudoux; P Defechereux; B Rentier; M P Merville
    Enhancement of varicella-zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins.
    Journal of medical virology 1996;49(4):264-73.
  • 1996: P Defechereux; S Debrus; L Baudoux; S Schoonbroodt; M P Merville; B Rentier; J Piette
    Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein.
    The Journal of general virology 1996;77 ( Pt 7)():1505-13.
  • 1995: J Piette; P Defechereux; L Baudoux; S Debrus; M P Merville; B Rentier
    Varicella-zoster virus gene regulation.
    Neurology 1995;45(12 Suppl 8):S23-7.
  • 1995: E Dejardin; G Bonizzi; A Bellahcène; V Castronovo; M P Merville; V Bours
    Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
    Oncogene 1995;11(9):1835-41.
  • 1995: L Baudoux; P Defechereux; S Schoonbroodt; M P Merville; B Rentier; J Piette
    Mutational analysis of varicella-zoster virus major immediate-early protein IE62.
    Nucleic acids research 1995;23(8):1341-9.
  • 1995: C Charlier; A Chariot; N Antoine; M P Merville; J Gielen; V Castronovo
    Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells.
    Biochemical pharmacology 1995;49(3):351-8.
  • 1994: A Bellahcène; M P Merville; V Castronovo
    Expression of bone sialoprotein, a bone matrix protein, in human breast cancer.
    Cancer research 1994;54(11):2823-6.
  • 1994: A Bellahcene; M P Merville; J Gielen; R Lambotte; L Simar; V Castronovo
    [Protein P53, protector of genome integrity: its role in carcinogenesis].
    Revue médicale de Liège 1994;49(5):274-84.
  • 1994: V Bours; E Dejardin; F Goujon-Letawe; M P Merville; V Castronovo
    The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines.
    Biochemical pharmacology 1994;47(1):145-9.
  • 1994: C Charlier; C Colin; M P Merville; J Gielen; R Lambotte; G Plomteux; V Castronovo
    [Tamoxifen in the treatment of breast cancer].
    Journal de gynécologie, obstétrique et biologie de la reproduction 1994;23(7):751-6.
  • 1993: M A Lauricella-Lefebvre; V Castronovo; H Sato; M Seiki; D L French; M P Merville
    Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells.
    Invasion & metastasis 1993;13(6):289-300.
Register to see more